AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 36.36 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $78.423 million which beat the analyst consensus estimate of $76.767 million by 2.16 percent. This is a 8.91 percent increase over sales of $72.004 million the same period last year.